Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Hoffmann-La Roche
Jonsson Comprehensive Cancer Center
Novelty Nobility, Inc.
University of Pittsburgh
Melanoma and Skin Cancer Trials Limited
Melanoma and Skin Cancer Trials Limited
RECORDATI GROUP
Excel Diagnostics and Nuclear Oncology Center
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
University of California, San Francisco
Vanderbilt-Ingram Cancer Center
Merck Sharp & Dohme LLC